Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Prospective Study Evaluating the Impact of Conservative Management on Retained Products of Conception and EMV

The goal of this observational study is to learn about the therapeutic effects of the conservative treatment approach on pepole with retained products of conception (RPOC) and Enhanced myometrial vascularity (EMV). The main question it aims to answer is: Is it possible to achieve the natural resolution of RPOC by combining it with EMV through conservative treatment? Participants will receive conservative treatment (such as mifepristone, GnRH-a, or expectant management) following the initial diagnosis of RPOC and EMV, and the therapeutic efficacy of the conservative approach will be assessed after the completion of two menstrual cycles.

Participants needed: 120
Trial details
Biological sex: FemaleType: ObservationalSponsor: Fu Xing Hospital, Capital Medical UniversityUpdated: Jun 15, 2025Locations: 1
Eligibility criteria

Recent history of miscarriage or delivery (within the past 8 weeks) [+3]

Heavy vaginal bleeding (requiring immediate surgical intervention) [+6]

Status: Not yet recruiting

Hysteroscopic "360°" Surgery for Improvement of Symptoms in Cesarean Scar Defects

Patients with symptomatic Cesarean Scar Defect (CSD) who are expected to undergo hysteroscopic surgery will be randomly divided into the traditional hysteroscopic "channelization" treatment group and the hysteroscopic "360 °" Surgery group of cesarean diverticulum, and the improvement of postoperative clinical symptoms of the two groups will be compared. To evaluate the effectiveness of the two surgical methods. The purpose of this study was to evaluate the improvement of symptoms of women with symptomatic cesarean diverticulum through a high-quality randomized controlled study, in order to provide high-level evidence-based medical evidence for clinical treatment.

Participants needed: 88
Trial details
Age: 18-45Biological sex: FemaleType: InterventionalSponsor: Fu Xing Hospital, Capital Medical UniversityUpdated: May 16, 2025
Eligibility criteria

Patients with surgical adaptation: changes in menstruation after cesarean sectio... [+5]

Patients with other diseases that may cause abnormal uterine bleeding (including... [+1]

Status: Recruiting

The Efficacy of Auto-cross Linked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception

Retained product of conception (RPOC) is defined by abnormal trophoblastic persistence or retained placenta inside the uterus cavity after a pregnancy independently of the outcome. Untreated RPOC can compromise future fertility. RPOC are generally treated surgically, either by repeated evacuation or by hysteroscopy, which exposes the uterus to additional potential trauma.The combination of trauma to the gravid uterine cavity, hypoestrogenic state at the time of the operation or immediately afterward and local infection is considered to be the pathogenic mechanism of intrauterine adhesions (IUA) , manifested clinically by menstrual abnormalities, infertility and recurrent pregnancy loss.To investigate the efficacy of auto-cross linked hyaluronic acid gel in the prevention of adhesion reformation after hysteroscopic resection of retained products of conception. After the completion of hysteroscopic resection of retained products of conception, patients will be randomized to one of the two groups by computer-generated numbers: \[1\] infusing auto-cross linked hyaluronic acid gel into intrauterine cavity in the experimental group; \[2\] no auto-cross linked hyaluronic acid gel into intrauterine cavity in the control group. Second and third look outpatient hysteroscopy will be performed 4 and 8 weeks after the initial surgery. The patients will be followed up about menstrual pattern at 3 months after the surgery.The patients will be followed up about pregancy outcome at 12 months after the surgery.

Participants needed: 86
Trial details
Age: 18-45Biological sex: FemaleType: InterventionalSponsor: Fu Xing Hospital, Capital Medical UniversityUpdated: Mar 12, 2025Locations: 1
Eligibility criteria

Clinical diagnosis of retained products of conception [+1]

Patients with severe complications of medicine and surgery [+2]